Carl Zeiss Meditec AG Cash Flow Conversion Efficiency
Carl Zeiss Meditec AG cash flow conversion efficiency. Based on the latest financial reports, Carl Zeiss Meditec AG (AFX) has a cash flow conversion efficiency ratio of 0.068x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (€144.16 Million ≈ $168.54 Million USD) by net assets (€2.13 Billion ≈ $2.49 Billion USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Cash Flow Conversion Efficiency of Carl Zeiss Meditec AG (2014–2025)
Cash flow conversion efficiency of Carl Zeiss Meditec AG from 2014 to 2025. This chart illustrates how Carl Zeiss Meditec AG's cash flow conversion efficiency has evolved over time, based on yearly financial data. View Carl Zeiss Meditec AG stock price for real-time trading data and today's change.
Carl Zeiss Meditec AG Cash Flow Conversion Ratio Explained
Carl Zeiss Meditec AG cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.
Carl Zeiss Meditec AG Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Carl Zeiss Meditec AG ranked by their cash flow conversion efficiency. Also see AFX company net worth for the company's overall valuation and market capitalisation.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Inesa Intelligent Tech Inc A
SHG:600602
|
-0.009x |
|
Hong Ri Da Technology Co. Ltd. A
SHE:301285
|
N/A |
|
Northwest Bancshares Inc
NASDAQ:NWBI
|
0.017x |
|
Verallia
PA:VRLA
|
0.210x |
|
Yangtze Optical Electronic Co. Ltd. A
SHG:688143
|
N/A |
|
Auren Energia S.A.
SA:AURE3
|
0.044x |
|
Diamond Power Infrastructure Limited
NSE:DIACABS
|
0.340x |
|
Jyoti CNC Automation Limited
NSE:JYOTICNC
|
0.007x |
Annual Cash Flow Conversion Efficiency for Carl Zeiss Meditec AG (2014–2025)
The table below shows the annual cash flow conversion efficiency of Carl Zeiss Meditec AG from 2014 to 2025. Review how much free cash does Carl Zeiss Meditec AG generate to assess how much free cash flow the company generates relative to operating cash flow.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-09-30 | €2.13 Billion ≈ $2.49 Billion |
€209.86 Million ≈ $245.35 Million |
0.099x | -17.99% |
| 2024-09-30 | €2.06 Billion ≈ $2.40 Billion |
€247.32 Million ≈ $289.14 Million |
0.120x | +4.17% |
| 2023-09-30 | €2.17 Billion ≈ $2.54 Billion |
€250.86 Million ≈ $293.28 Million |
0.115x | +24.53% |
| 2022-09-30 | €2.03 Billion ≈ $2.37 Billion |
€188.20 Million ≈ $220.02 Million |
0.093x | -57.12% |
| 2021-09-30 | €1.68 Billion ≈ $1.96 Billion |
€362.66 Million ≈ $423.99 Million |
0.216x | +75.67% |
| 2020-09-30 | €1.45 Billion ≈ $1.70 Billion |
€178.53 Million ≈ $208.72 Million |
0.123x | -20.60% |
| 2019-09-30 | €1.42 Billion ≈ $1.66 Billion |
€219.63 Million ≈ $256.78 Million |
0.155x | +8.85% |
| 2018-09-30 | €1.31 Billion ≈ $1.54 Billion |
€187.21 Million ≈ $218.86 Million |
0.142x | +368.64% |
| 2017-09-30 | €1.24 Billion ≈ $1.45 Billion |
€37.73 Million ≈ $44.11 Million |
0.030x | -76.86% |
| 2016-09-30 | €851.16 Million ≈ $995.10 Million |
€111.77 Million ≈ $130.67 Million |
0.131x | +84.54% |
| 2015-09-30 | €797.45 Million ≈ $932.30 Million |
€56.74 Million ≈ $66.34 Million |
0.071x | -14.95% |
| 2014-09-30 | €754.23 Million ≈ $881.77 Million |
€63.10 Million ≈ $73.78 Million |
0.084x | -- |
About Carl Zeiss Meditec AG
Carl Zeiss Meditec AG operates as a medical technology company in Germany, rest of Europe, North America, and Asia. It operates in two segments, Ophthalmology and Microsurgery. The Ophthalmology segment offers products and solutions for the diagnosis and treatment of chronic eye diseases, including slit lamps, refractometers, and tonometers; optical coherence tomography and fundus cameras for ret… Read more